Relievus Pain Management – Wyomissing, Pennsylvania Ketamine Clinics

People suffering from chronic pain and psychological conditions can find relief from their symptoms at Relievus Pain Management. The clinic provides cutting-edge ketamine therapy treatments to people with complex regional pain syndrome, reflex sympathetic dystrophy, and major depression. These disorders are often difficult to treat and unresponsive to treatment, but ketamine has shown to be a successful option in over 70 percent of patients. 

The medical team at Relievus Pain Management is compassionate and devoted to helping their patients regain a sense of control over their health conditions. They strive to help as many people as possible. By offering the latest in chronic pain therapy treatments, they can help people recover and heal from their chronic pain conditions and mood disorders one ketamine infusion at a time.

Offered Treatments

• IV Ketamine Infusion Therapy

Treated Conditions

• CRPS (Complex Regional Pain Syndrome) or RSD (Reflex Sympathetic Dystrophy)
• Major Depression

Important Info

• Patients do not need a referral; however, they will need to provide documentation from their primary care, pain specialist, psychiatrist, or therapist related to their diagnosis and past treatment. Patients will be required to continue regular ongoing contact with them during and after ketamine infusions.
• Relievus Pain Management’s ketamine treatments have no formal age limitations.
• Those with uncontrolled blood pressure, unstable heart disease, untreated thyroid disease, active substance abuse, along with anyone currently in the manic phase of bipolar disorder or experiencing active psychotic symptoms (hallucinations or delusions), might not be eligible for ketamine therapy at Relievus Pain Management.
• Ketamine infusion costs vary (see Relievus Pain Management’s pricing below), and since insurance providers rarely cover these treatments, it’s best to check with your carrier beforehand.

Your Treatment: What to Expect at Relievus Pain Management

A preliminary consultation and evaluation of your medical history will determine if you’re a worthwhile candidate for ketamine and assess if you have any health conditions that make ketamine unsafe. If you’re approved to proceed with ketamine infusion therapy, Relievus Pain Management typically begins with one or two infusions back to back to see if they are effective for you.

During the infusions, ketamine is administered over a period of 45 minutes to 60 minutes. The amount given will not cause you to lose consciousness. During the infusion, most patients have a mild dissociative experience, with increased sensitivity to light and sound and an altered perception of time and color. Most patients tolerate these experiences without discomfort and many people find them to be pleasant. In the rare case these side effects are considered unpleasant, other rapid-acting medications can be used to relieve or eliminate this discomfort. Once the infusion is complete, the dissociative effects of the drug rapidly dissipate and are often mostly gone within 20-30 minutes. There are no delayed “flashbacks” and patients generally leave Relievus Pain Management’s offices within 30 minutes following the infusion and aside from mild fatigue, feel much like themselves.

Most patients who respond to the infusions see some improvement the day of or after their second infusion. If not, Relievus Pain Management may attempt a longer and/or higher dose infusion. If there is still no response, the clinic generally stops further treatment. If ketamine does improve your mood, outlook, and functionality, Relievus Pain Management suggests that you receive 2-4 additional infusions over the next 4 weeks (1-2 infusions every 2 weeks) to maximize ketamine’s brain-repairing abilities. That is a total of 6 infusions for one full series.

Discover more Relievus Pain Management Locations:

• Havertown, Pennsylvania
• Vineland, New Jersey
• North Brunswick, New Jersey
• Pennsauken, New Jersey
• Sewell, New Jersey

Pricing

Location

Review (1)